memantine has been researched along with latrepirdine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bachurin, SO; Dranyi, OA; Grigorev, VV | 1 |
| Bachurin, SO; Kireeva, EG; Shevtsova, EF | 1 |
| van Marum, RJ | 1 |
| Kovács, T | 1 |
| Alfaro, IE; Altar, CA; Bernales, S; Cremers, T; Drieu La Rochelle, C; Gibbons, JA; Giorgetti, M; Hutter-Paier, B; Protter, AA; Wronski, R | 1 |
| Shoji, M | 1 |
| Gravitz, L | 1 |
3 review(s) available for memantine and latrepirdine
| Article | Year |
|---|---|
Current and future therapy in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Docosahexaenoic Acids; Estrogen Replacement Therapy; Excitatory Amino Acid Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunotherapy; Indoles; Memantine; Receptors, N-Methyl-D-Aspartate | 2008 |
[Therapy of Alzheimer disease].
Topics: Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Cognition; Dopamine Agents; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Memantine; Neurofibrillary Tangles; Neuroprotective Agents; Nootropic Agents; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; tau Proteins | 2009 |
[Drug therapy for Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Clioquinol; Drug Design; Excitatory Amino Acid Antagonists; Flurbiprofen; Indoles; Memantine; Meta-Analysis as Topic; Randomized Controlled Trials as Topic | 2010 |
5 other study(ies) available for memantine and latrepirdine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons.
Topics: Animals; Benzothiadiazines; Cerebral Cortex; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Indoles; Kainic Acid; Memantine; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Purkinje Cells; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2003 |
[Mitochondria as the target for neuroprotectors].
Topics: Animals; Antiparkinson Agents; Brain; Cell Death; Cells, Cultured; Dopamine Agents; Ginkgo biloba; Indoles; Intracellular Membranes; Ion Channels; Lipid Peroxidation; Memantine; Mitochondria; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxins; Nootropic Agents; Permeability; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Tacrine | 2005 |
Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Behavior, Animal; Brain Chemistry; Cholinesterase Inhibitors; Cognition; Donepezil; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Indans; Indoles; Male; Memantine; Microdialysis; Piperidines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology | 2010 |
Drugs: a tangled web of targets.
Topics: Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azepines; Clinical Trials as Topic; Disease Progression; Genetic Therapy; Glycogen Synthase Kinase 3; Humans; Indoles; Memantine; Methylene Blue; Molecular Targeted Therapy; Nerve Growth Factor; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 2011 |